Key result
Calcium channel blockers, particularly dihydropyridines like amlodipine, are supported by extensive evidence for the treatment of hypertension and associated cardiovascular diseases.
Answers are grounded in this paper and cite their sources.
A review of the evidence favoring calcium channel blockers, particularly dihydropyridines like amlodipine, in the treatment of hypertension and cardiovascular diseases.
Despite the presence of an artificial debate developed in the past decade1,2 focusing on calcium channel blockers and their role in the prevention and treatment of cardiovascular diseases, a huge amount of evidence has been created favouring this class of agents in the treatment of hypertension and associated cardiovascular diseases.3 Calcium channel blockers are divided into three classes, the most popular of which are the dihydropyridines.
No takes yet. Share an insight, caveat, or question.
Alejandro de la Sierra (2007) conducted a review in Hypertension and cardiovascular disease. Amlodipine (Calcium channel blockers) was evaluated. Calcium channel blockers, particularly dihydropyridines like amlodipine, are supported by extensive evidence for the treatment of hypertension and associated cardiovascular diseases.
Synapse has enriched 10 related papers. Consider them for comparative context: